| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 01/15/2013 | CA2430133C Cyclic salen-metal compounds: reactive oxygen species scavengers useful as antioxidants in the treatment and prevention of diseases |
| 01/15/2013 | CA2406725C Edg8 receptor, its preparation and use |
| 01/10/2013 | WO2013005836A1 Fructose absorption inhibitor |
| 01/10/2013 | WO2013005834A1 Anti-obesity agent comprising high-purity epa |
| 01/10/2013 | WO2013005798A1 Novel nitrogenated heterocyclic ring derivative |
| 01/10/2013 | WO2013005760A1 Adhesive skin patch containing serotonin receptor antagonist drug |
| 01/10/2013 | WO2013005755A1 Methylpiperidine derivative |
| 01/10/2013 | WO2013005514A1 Skin-improving agent for oral intake |
| 01/10/2013 | WO2013005403A1 Method for determination of onset sensitivity or onset resistance to heat stroke |
| 01/10/2013 | WO2013005354A1 Heterocyclic compound |
| 01/10/2013 | WO2013004828A1 Carboxylic acid derivatives having an oxazolo[4,5-c]pyridine ring |
| 01/10/2013 | WO2013004827A1 Carboxylic acid derivatives having an oxazolo[5,4-d]pyridine ring |
| 01/10/2013 | WO2012018115A9 Composition for regenerating normal tissue from fibrotic tissue |
| 01/10/2013 | US20130012692 Sodium channel blockers |
| 01/10/2013 | US20130012590 Subcutaneous fat reduction |
| 01/10/2013 | US20130012588 Compositions and methods for prevention and treatement of wounds |
| 01/10/2013 | US20130012567 RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING CHEMICALLY MODIFIED SHORT INTERFERING NUCLEIC ACID (siNA) |
| 01/10/2013 | US20130012498 5ht2c receptor modulators |
| 01/10/2013 | US20130012495 5ht2c receptor modulators |
| 01/10/2013 | US20130012459 Composition for inhibiting the onset of arteriosclerosis and inhibition method |
| 01/10/2013 | US20130012441 Prediction and prevention of preeclampsia |
| 01/10/2013 | US20130011861 Modulators of p-selectin glycoprotein ligand 1 |
| 01/10/2013 | US20130011465 Composition and method for the treatment of diseases affected by apoptosis |
| 01/10/2013 | CA2841229A1 Carboxylic acid derivatives having an oxazolo[4,5-c]pyridine ring |
| 01/10/2013 | CA2841226A1 Carboxylic acid derivatives having an oxazolo[5,4-d]pyrimidine ring |
| 01/10/2013 | CA2840985A1 Anti-obesity agent comprising high-purity epa |
| 01/10/2013 | CA2840983A1 Adhesive skin patch containing serotonin receptor antagonist drug |
| 01/09/2013 | EP2543390A1 Pharmaceutical composition |
| 01/09/2013 | EP2543385A1 Novel analgesics |
| 01/09/2013 | EP2543382A1 Agent for preventing muscular atrophy |
| 01/09/2013 | EP2543381A1 Immunoglobulin a secretion promoter |
| 01/09/2013 | EP2543380A1 Neural stem cells proliferation promoting agent |
| 01/09/2013 | CN102869665A Benzazepine compound |
| 01/09/2013 | CN102869656A Tetrahydrobenzothiophene compound |
| 01/09/2013 | CN102869375A Immunogenic composition comprising s. pneumoniae polysaccharides conjugated to carrier proteins |
| 01/09/2013 | CN102863432A Modulators of cftr |
| 01/09/2013 | CN102863362A Aryl compounds as ppar ligands and their use |
| 01/09/2013 | CN102861267A Traditional Chinese medicine prescription for treating exudative pleurisy |
| 01/09/2013 | CN102861211A Blood-activating and meridian obstruction-removing tablet |
| 01/09/2013 | CN102861192A Medicine composition for chronic renal failure and peritoneal fibrosis |
| 01/09/2013 | CN102379883B Pharmaceutical composition of glycerin fructose injection |
| 01/09/2013 | CN101969953B Pterin analog for treating bh4 responsive condition |
| 01/09/2013 | CN101921319B Rubiaceae-type cyclopeptides, medicinal compositions using same as active ingredients, and preparation method and application thereof |
| 01/09/2013 | CN101798298B Imidazole derivatives |
| 01/09/2013 | CN101787078B Collagen polypeptide, preparation method and application thereof |
| 01/09/2013 | CN101400655B Quinolone derivative or pharmaceutically acceptable salt thereof |
| 01/09/2013 | CN101223158B N-dihydroxyalkyl-substituted 2-oxo-imidazole derivatives |
| 01/08/2013 | US8350076 Sodium channel blockers |
| 01/08/2013 | US8350060 2-amino-bicyclo[3.1.0] hexane-2, 6-dicarboxylic ester derivative |
| 01/08/2013 | US8350016 Oligonucleotide compositions and their use to induce apoptosis |
| 01/08/2013 | US8349888 Phytoestrogenic isoflavone compositions, their preparation and use thereof for protection against and treatment of radiation injury |
| 01/08/2013 | US8349853 Detection defect in gene expression of hedgehog gene; diagnosis of cancer |
| 01/08/2013 | CA2696826C Process for preparing inhibitors of nucleoside metabolism |
| 01/08/2013 | CA2677315C Pyrimidinylaminobenzamide derivatives and their use as inhibitors of tyrosine kinases |
| 01/08/2013 | CA2677176C Inhibition of bcl-2 protein expression by liposomal antisense oligodeoxynucleotides |
| 01/08/2013 | CA2655644C Solution and method to reduce, treat and/or prevent oxidative stress and cell activation |
| 01/08/2013 | CA2642665C Anti-cancer pharmaceutical composition |
| 01/08/2013 | CA2585560C Use of acetyl l-carnitine for the treatment of fibromyalgic syndrome |
| 01/08/2013 | CA2571884C Hyaluronic acid in the enhancement of lens regeneration |
| 01/08/2013 | CA2507710C Tricyclic pyrazole derivatives and their use as cb1 or cb2 modulators |
| 01/08/2013 | CA2478065C Macrocyclic compounds useful as pharmaceuticals |
| 01/08/2013 | CA2456271C Use of lysyl oxidase inhibitors for cell culture and tissue engineering |
| 01/08/2013 | CA2447671C Trisubstituted-n-[(1s)-1,2,3,4-tetrahydro-1-naphthalenyl] benzamides which inhibit p2x3 and p2x2/3 containing receptors |
| 01/08/2013 | CA2441577C Therapeutic agents for inflammatory bowel diseases |
| 01/08/2013 | CA2423595C Plasminogen activator to prevent corneal and subepithelial haze after laser vision correction surgery |
| 01/03/2013 | WO2013002365A1 Antipruritic agent |
| 01/03/2013 | WO2013002196A1 Novel pharmaceutical composition |
| 01/03/2013 | WO2013001890A1 Soyasapogenol composition |
| 01/03/2013 | WO2013000395A1 Novel histone deacetylase inhibitor of benzamides and use thereof |
| 01/03/2013 | US20130005727 Quinazoline derivatives |
| 01/03/2013 | US20130005701 Substituted oxazolidinones and their use in the field of blood coagulation |
| 01/03/2013 | US20130004559 Flat self-curling permeable sheet membrane |
| 01/03/2013 | US20130004494 Inhibition of P21 and Use Thereof for Inducing Tissue Regeneration |
| 01/03/2013 | US20130004485 Humanized and chimeric anti-properdin antibodies |
| 01/03/2013 | US20130004470 p27 AND p21 IN GENE THERAPIES |
| 01/03/2013 | US20130004467 Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cells |
| 01/03/2013 | CA2840480A1 Antipruritic agent |
| 01/02/2013 | EP2540728A1 Heterocyclic compound |
| 01/02/2013 | EP2540720A1 1,3,4,8-tetrahydro-2h-pyrido[1,2-a]pyrazine derivative and use of same as hiv integrase inhibitor |
| 01/02/2013 | EP2540315A1 Agent for controlling production of primary bile acid and secondary bile acid |
| 01/02/2013 | EP2540308A1 Therapeutic agent for eating disorders |
| 01/02/2013 | EP2540300A1 Epithelial cell-cell adhesion enhancer, and ameliorating, therapeutic or prophylactic agent for allergic diseases using same |
| 01/02/2013 | EP2539342A1 Pyrazolopyrimidine compounds and their use as pde10 inhibitors |
| 01/02/2013 | EP2538978A1 Use of ep4 receptor antagonists in the treatment of il-23 mediated diseases |
| 01/02/2013 | EP2538961A2 Methods for inhibiting necrosis |
| 01/02/2013 | EP2538960A1 Surfactant composition |
| 01/02/2013 | EP2538780A1 Estrogen receptor ligands and methods of use thereof |
| 01/02/2013 | EP2182949B1 (2s,3r)-n-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofuran-2-carboxamide, novel salt forms, and methods of use thereof |
| 01/02/2013 | CN1551781B One dose vaccination with mycoplasma hyopneumoniae |
| 01/02/2013 | CN102858978A High-purity soluble thrombomodulin and method for producing same |
| 01/02/2013 | CN102858772A Imidazo[1,2-a]pyridine derivative |
| 01/02/2013 | CN102858771A 1,3,4,8-tetrahydro-2h-pyrido[1,2-a]pyrazine derivative and use of same as HIV integrase inhibitor |
| 01/02/2013 | CN102858355A Expression Modulator For Clock Gene Bmal |
| 01/02/2013 | CN102858340A Prophylactic or therapeutic agent for diseases associated with pains in urinary organs |
| 01/02/2013 | CN102858334A Composition for amelioration of hypoalbuminemia |
| 01/02/2013 | CN102858329A Compounds for use in the treatment of diseases |
| 01/02/2013 | CN102851183A Ophiopogon japonicus health wine with effects of removing heart-fire and relieving restlessness |
| 01/02/2013 | CN102850436A Growth hormone releasing peptides |
| 01/02/2013 | CN102850345A Quaternary ammonium salt and its pharmaceutical composition and its use |
| 01/02/2013 | CN102850236A Novel benzamide histone deacetylase inhibitor and application thereof |